Cargando…
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Multi-drug resistance (MDR) is a leading cause of cancer-related death, and it continues to be a major barrier to cancer treatment. The tumour microenvironment (TME) has proven to play an essential role in not only cancer progression and metastasis, but also the development of resistance to chemothe...
Autores principales: | Seebacher, Nicole A., Krchniakova, Maria, Stacy, Alexandra E., Skoda, Jan, Jansson, Patric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615091/ https://www.ncbi.nlm.nih.gov/pubmed/34829672 http://dx.doi.org/10.3390/antiox10111801 |
Ejemplares similares
-
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma
por: Borankova, Karolina, et al.
Publicado: (2023) -
A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC
por: Seebacher, Nicole A, et al.
Publicado: (2016) -
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
por: Krchniakova, Maria, et al.
Publicado: (2020) -
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma
por: Macsek, Peter, et al.
Publicado: (2021) -
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
por: Paukovcekova, Silvia, et al.
Publicado: (2022)